Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double-blind, placebo-controlled trial.
Bril V, Berkowicz T, Szczudlik A, Nicolle MW, Bednarik J, Hon P, Vaitkus A, Vu T, Rozsa C, Magnus T, Panczel G, Toomsoo T, Pasnoor M, Mozaffar T, Freimer M, Reuner U, Vécsei L, Souayah N, Levine T, Pascuzzi RM, Dalakas MC, Rivner M, Griffin R, Coll MQ, Mondou E. Bril V, et al. Among authors: mondou e. Muscle Nerve. 2025 Jan;71(1):43-54. doi: 10.1002/mus.28289. Epub 2024 Nov 7. Muscle Nerve. 2025. PMID: 39506903 Free PMC article. Clinical Trial.
A Phase 3, Randomized, Active-controlled, Single-blind Clinical Trial to Evaluate the Efficacy of Fibrin Sealant Grifols in Achieving Hemostasis in Pediatric Surgery.
Balanescu L, Gajdobranski D, Sretenović A, Kalinova K, Vajda P; Fibrin Sealant Pediatric Surgery Study Group; Hanna K, Querolt M, Camprubí S, Mondou E. Balanescu L, et al. Among authors: mondou e. J Pediatr Surg. 2024 Nov;59(11):161639. doi: 10.1016/j.jpedsurg.2024.07.024. Epub 2024 Jul 23. J Pediatr Surg. 2024. PMID: 39142955 Free article. Clinical Trial.
Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial.
Alemany A, Millat-Martinez P, Corbacho-Monné M, Suñer C, Galvan-Casas C, Carrera C, Ouchi D, Prat N, Ara J, Nadal N, Riel R, Funollet B, Ojeda-Ciurana C, Balague LE, Salvador-González B, Arcarons AF, Vidal-Alaball J, Del Cura-González MI, Barrientos RR, Ramos-Blanes R, Bou AA, Mondou E, Torres M, Campins N, Sanz A, Tang Y, Rodriguez-Arias MÀ, Bassat Q, Clotet B; GC2010 STUDY GROUP; Mitjà O. Alemany A, et al. Among authors: mondou e. EClinicalMedicine. 2023 Mar 10;57:101898. doi: 10.1016/j.eclinm.2023.101898. eCollection 2023 Mar. EClinicalMedicine. 2023. PMID: 36936402 Free PMC article.
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.
Bril V, Szczudlik A, Vaitkus A, Rozsa C, Kostera-Pruszczyk A, Hon P, Bednarik J, Tyblova M, Köhler W, Toomsoo T, Nowak RJ, Mozaffar T, Freimer ML, Nicolle MW, Magnus T, Pulley MT, Rivner M, Dimachkie MM, Distad BJ, Pascuzzi RM, Babiar D, Lin J, Querolt Coll M, Griffin R, Mondou E. Bril V, et al. Among authors: mondou e. Neurology. 2023 Feb 14;100(7):e671-e682. doi: 10.1212/WNL.0000000000201501. Epub 2022 Oct 21. Neurology. 2023. PMID: 36270895 Free PMC article. Clinical Trial.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Antithrombin Supplementation in Patients at Risk for Antithrombin Deficiency After Cardiac Surgery.
Moront MG, Woodward MK, Essandoh MK, Avery EG, Reece TB, Brzezinski M, Spiess B, Shore-Lesserson L, Chen J, Henriquez W, Barceló M, Despotis G, Karkouti K, Levy JH, Ranucci M, Mondou E; Clinical Thrombate Study Group. Moront MG, et al. Among authors: mondou e. Anesth Analg. 2022 Oct 1;135(4):757-768. doi: 10.1213/ANE.0000000000006145. Epub 2022 Jul 25. Anesth Analg. 2022. PMID: 35877927 Clinical Trial.
Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
Santamaria M, Neth O, Douglass JA, Krivan G, Kobbe R, Bernatowska E, Grigoriadou S, Bethune C, Chandra A, Horneff G, Borte M, Sonnenschein A, Kralickova P, Ramón SS, Langguth DD, Gonzalez-Granado LI, Alsina L, Querolt M, Griffin R, Hames C, Mondou E, Price J, Sanz A, Lin J. Santamaria M, et al. Among authors: mondou e. J Clin Immunol. 2022 Apr;42(3):512-513. doi: 10.1007/s10875-022-01219-3. J Clin Immunol. 2022. PMID: 35174440 Free PMC article. No abstract available.
A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
Santamaria M, Neth O, Douglass JA, Krivan G, Kobbe R, Bernatowska E, Grigoriadou S, Bethune C, Chandra A, Horneff G, Borte M, Sonnenschein A, Kralickova P, Ramón SS, Langguth D, Gonzalez-Granado LI, Alsina L, Querolt M, Griffin R, Hames C, Mondou E, Price J, Sanz A, Lin J. Santamaria M, et al. Among authors: mondou e. J Clin Immunol. 2022 Apr;42(3):500-511. doi: 10.1007/s10875-021-01181-6. Epub 2022 Jan 1. J Clin Immunol. 2022. PMID: 34973143 Free PMC article.
42 results